Short treatment of peripheral blood cells product with Fas ligand using closed automated cell processing system significantly reduces immune cell reactivity of the graft in vitro and in vivo.

Rodionov, Galina; Rosenzwaig, Michal; Tzadok, Michal Schrift; Kvint, Moran; Gevir, Elazar; Zorde-Khvalevsky, Elina; Peled, Amnon; Yarkoni, Shai; Ofer, Amos

Rodionov, Galina; Rosenzwaig, Michal; Tzadok, Michal Schrift; Kvint, Moran; Gevir, Elazar; Zorde-Khvalevsky, Elina; Peled, Amnon; Yarkoni, Shai; Ofer, Amos.

Affiliation

Rodionov G; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel.
Rosenzwaig M; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel.
Tzadok MS; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel.
Kvint M; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel.
Gevir E; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel.
Zorde-Khvalevsky E; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.
Peled A; Goldyne Savad Institute of Gene Therapy, Hebrew University of Jerusalem, Jerusalem, Israel.
Yarkoni S; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel.
Ofer A; Cellect Biotherapeutics Ltd, Kfar-Saba, Israel. amoso@cellect.co.

Bone Marrow Transplant ; 57(8): 1250-1259, 2022 08.

Article in En | MEDLINE | ID: mdl-35538142

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Graft vs Host Disease Limits: Animals Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2022 Document type: Article Affiliation country: Israel Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google